Hematology Analyzers Market Trends

Growth Drivers

• An aging population globally: An aging population increases the likelihood of a growing prevalence of hematological and chronic disorders. As disclosed by the National Council on Aging in July 2025, around 93% of adults aged over 65 and older suffer from at least 1 chronic illness, while 79% have two or more. In February 2025, the World Health Organization estimated that by 2030, around 1.4 billion people are expected to be aged 65 and over, from 1.1 billion in 2023. Based on all these facts, it can be assumed that the demand for hematology analyzers in different healthcare settings can increase sharply over the next few years.
• The trend of early disease detection and prevention: Healthcare organizations are increasingly adopting predictive modelling to enable early detection and prevention of diseases, such as cancer, heart disorders, and Alzheimer’s. Growing deaths due to the occurrence of noncommunicable diseases drive the need for the adoption of measures for early diseases and prevention in different healthcare settings. As projected by the World Health Organization in February 2025, around 30 to 50% of cancers can currently be cured by avoiding risk factors and applying available evidence-based prevention tactics. Hematology analyzers are supposed to play a crucial role in strengthening early detection and prevention of diseases by allowing for rapid analysis of blood samples with utmost accuracy.
• Improvement of healthcare infrastructure: Leaders of different health systems globally are striving for efficiencies, productivity, and enhancement of patient engagement. Governments in developing economies are also active in massive investments for the development of healthcare infrastructure. As revealed by the India Brand Equity Foundation in May 2025, the union budget for the development, enhancement, and maintenance of the healthcare system of the country was USD 11.5 billion in 2025. The efforts to develop healthcare infrastructure can accelerate the adoption of hematology analyzers in different healthcare settings, including hospitals. In addition, access to adequate funding is also there to expand the diagnostic capabilities of the medical devices through investment in research and development.

Challenges

• Lack of a skilled workforce: The engagement of a technologically skilled workforce is required for the efficient operation of modern-day hematology analyzers. A report released in November 2023 revealed that hiring suitable employees became challenging for 77% of employers in the high-demand sector, where the engagement of tech-savvy people is integral. The World Health Organization has also estimated a lack of 11 million health workers by 2030. The shortage of the mentioned types of workers in the healthcare sector can hinder the adoption of the advanced hematology analyzers.
• Disruptions in the supply chain: A wide range of geopolitical landscapes, including poor political relations between countries, natural disasters, and others, can create operational hurdles and a shortage of raw materials, such as control units, power sources, and sample trays that are required for the manufacturing of the hematology analyzers. This can cause delays in the completion of the production of hematology analyzers. The operations of the medical device also rely on certain regents, including sodium chloride, purified water, buffers, sodium sulfate, and others. In March 2024, the United Nations reported that around 50% of the global population, which accounts for approximately 4 billion suffer issues with a shortage of water for at least a month of the year.  The shortage of reagents can lead hematology analyzers to go into standby mode in different healthcare settings.